Get started
Author

Jaisson Bortolini

Observed names: J Bortolini, J. Bortolini, Jaisson A.P. Bortolini, Jaisson Andre Pagnoncelli Bortolini, Jaisson André Pagnoncelli Bortolini
Observed institution: Centro de Pesquisas Oncológicas
ORCID: 0000-0001-7298-8570
Observed ORCID: 0000-0001-7298-8570
OpenAlex ID: A5077768491
COVID-19 in chronic myeloid leukemia patients in Latin America
2021 · Katia B. Pagnano, Evelyn Herrera Peralta, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study
2018 · Katia B Pagnano, Carmen Fava, et al. · Blood · 9
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis
2023 · Miguel A. Canales, Thomas A. Buchholz, et al. · HemaSphere · 7
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
2022 · Carla Boquimpani, Fernanda Salles Seguro, et al. · Hematology Transfusion and Cell Therapy · 7
PDF
Covid-19 in Chronic Myeloid Leukemia Patients – Brazilian Experience
2020 · K.B.B. Pagnano, A.C. Toreli, et al. · Hematology Transfusion and Cell Therapy · 3
Financial Impact of Imatinib Discontinuation in Brazil - a Pharmoeconomic Study
2019 · Renato Torrescasana Centrone, Isabel Bonafe, et al. · Blood · 3
A Multicenter Non-inferiority Study of Efficacy and Safety of Generic Imatinib in Chronic Myeloid Leukemia – Final Analysis
2021 · KBB Pagnano, ECM Miranda, et al. · Hematology Transfusion and Cell Therapy · 2
Covid-19 in Chronic Myeloid Leukemia Patients – Brazilian Experience
2021 · KBB Pagnano, AC Toreli, et al. · Hematology Transfusion and Cell Therapy · 2
Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma
2021 · Peter Trask, Jaisson Bortolini, et al. · Blood · 1
A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients
2021 · Leonardo Fechio, Ana Vitória Ferreira Mota, et al. · Blood · 1
PDF
Open-Label Early-Access Programs (EAPs) for Ibrutinib in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL) or Mantle-Cell Lymphoma (MCL)
2018 · Carlos Sérgio Chiattone, Nelson Hamerschlak, et al. · Blood · 1
Equity program: strategies on clinical studies as an aggregating potential
2023 · Edvan de Queiroz Crusoe, Abrahão Elias Hallack Neto, et al. · Hematology Transfusion and Cell Therapy
Avaliação Da Covid-19 Em Pacientes Com Leucemia Mieloide Crônica
2022 · LVDN Fechio, J Bortolini, et al. · Hematology Transfusion and Cell Therapy
Pb2083: Study Conduct and Patient Safety During the Covid-19 Pandemic: Observations in Patients With Previously Untreated Follicular Lymphoma From the Gazelle Trial of Obinutuzumab Short Duration Infusion
2022 · M. A. Canales, T. A. Buchholz, et al. · HemaSphere
Covid-19 - Resultados De Questionários Aplicados Em Pacientes Com Leucemia Mieloide Crônica Durante a Pandemia
2021 · L Fechio, J Bortolini, et al. · Hematology Transfusion and Cell Therapy
COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
2020 · Katia B Pagnano, Ana Carolina Mourão Toreli, et al. · Blood
PDF
Works count: 16
Citation count: 45
H-index: 4
I10-index:
Year
Topic
Type